Capital Market Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Sell |
670
-350
| -34% | -$156K | 0.21% | 99 |
|
|
2025
Q1 | $495K | Buy |
1,020
+20
| +2% | +$9.7K | 0.33% | 60 |
|
|
2024
Q4 | $403K | Sell |
1,000
-38
| -4% | -$15.3K | 0.23% | 93 |
|
|
2024
Q3 | $483K | Buy |
1,038
+5
| +0.5% | +$2.33K | 0.29% | 70 |
|
|
2024
Q2 | $484K | Sell |
1,033
-124
| -11% | -$58.1K | 0.31% | 65 |
|
|
2024
Q1 | $484K | Buy |
1,157
+207
| +22% | +$86.5K | 0.37% | 61 |
|
|
2023
Q4 | $387K | Sell |
950
-12
| -1% | -$4.88K | 0.34% | 73 |
|
|
2023
Q3 | $332K | Buy |
962
+84
| +10% | +$29K | 0.33% | 78 |
|
|
2023
Q2 | $309K | Buy |
+878
| New | +$309K | 0.29% | 89 |
|
|
2023
Q1 | – | Sell |
-870
| Closed | -$251K | – | 132 |
|
|
2022
Q4 | $251K | Hold |
870
| – | – | 0.27% | 104 |
|
|
2022
Q3 | $252K | Hold |
870
| – | – | 0.28% | 97 |
|
|
2022
Q2 | $245K | Hold |
870
| – | – | 0.26% | 108 |
|
|
2022
Q1 | $227K | Buy |
+870
| New | +$227K | 0.2% | 132 |
|